Expression Profile and Biological Role of Immune Checkpoints in Disease Progression of HIV/SIV Infection.

Abstract

During HIV/SIV infection, the upregulation of immune checkpoint (IC) markers, programmed cell death protein-1 (PD-1), cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), T cell immunoglobulin and ITIM domain (TIGIT), lymphocyte-activation gene-3 (LAG-3), T cell immunoglobulin and mucin domain-3 (Tim-3), CD160, 2B4 (CD244), and V-domain Ig suppressor of T cell activation (VISTA), can lead to chronic T cell exhaustion. These ICs play predominant roles in regulating the progression of HIV/SIV infection by mediating T cell responses as well as enriching latent viral reservoirs. It has been demonstrated that enhanced expression of ICs on CD4+ and CD8+ T cells could inhibit cell proliferation and cytokine production. Overexpression of ICs on CD4+ T cells could also format and prolong HIV/SIV persistence. IC blockers have shown promising clinical results in HIV therapy, implying that targeting ICs may optimize antiretroviral therapy in the context of HIV suppression. Here, we systematically review the expression profile, biological regulation, and therapeutic efficacy of targeted immune checkpoints in HIV/SIV infection.

• Authors: Yuting Sun, Jing Xue
• Journal: Viruses (Viruses) Vol. 14 Issue 3 (03 11 2022) ISSN: 1999-4915 [Electronic] Switzerland
• PMID: 35336991 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review, Systematic Review)

Chemical References

• Immunoglobulins

Topics

• Animals
• CD8-Positive T-Lymphocytes
• Disease Progression
• HIV Infections
• Humans
• Immunoglobulins (therapeutic use)
• Lymphocyte Activation
• Simian Acquired Immunodeficiency Syndrome
• Simian Immunodeficiency Virus